Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure

Liver Transplantation

Volumn 14, Issue 1, 2008, Pages 25-30

  Kortsalioudaki, Christine ^a   Taylor, Rachel M ^a   Cheeseman, Paul ^a   Bansal, Sanjay ^a   Mieli Vergani, Giorgina ^a   Dhawan, Anil ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIINFECTIVE AGENT; GLUCOSE; PARACETAMOL; RANITIDINE; SUCRALFATE;

ADOLESCENT; ALLERGIC REACTION; ARTICLE; BACTERIAL INFECTION; BRADYCARDIA; BRAIN DISEASE; BRONCHOSPASM; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOSIS; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROTHROMBIN TIME; SURVIVAL TIME; TACHYCARDIA;

ACETAMINOPHEN; ACETYLCYSTEINE; ADOLESCENT; ANALGESICS, NON-NARCOTIC; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; LIVER FAILURE, ACUTE; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 38649106486     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21246     Document Type: Article

References (35)

1. Dhawan A, Cheeseman P, Mielt-Vergani G. Approaches to acute liver failure in children. Pediatr Transplant 2004;8: 584-588.
2. Bansal S, Dhawan A. Acute liver failure. In: Walker A, Goulet AJ, Kleinman RE, Sherman PM, Shneider BL, Sanderson IR, eds. Pediatric gastro-intestinal disease: pathophysiology, diagnosis and management. Hamilton, ON; BC Becker, 2004:1491-1505.
3. Way SL, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Pediatr Gastroenterol Nutr 2005;40:575-581.
4. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 2000; 15:718-724.
5. Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R. Enhanced tumour necrosis factor and interleukin- 1 in fulminant hepatic failure. Lancet 1988;2: 72-74.
6. Nagaki M, Iwai H, Naild T, Ohnishi H, Muto Y, Moriwaki H. High levels of serum interleukin- 10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis J Infectious Dis 2000;182:1103-1108.
7. Iwai H, Nagaki M, Naito T, Ishiki Y, Murakami M, Sugihara J, et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998;26:873-876.
8. Izumi S, Hughes RD, Langley PG, Pernambuco JR, Williams R, Extent of the acute phase response in fulminant hepatic failure. Gut 1994;35:982-986.
9. Slattery JT, Wilson JM, Kalhorn TF, Nelson SD. Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans. Clin Pharmacol Ther 1987;41:413-418.
10. Miners JO, Drew R, Birkett DJ. Mechanism of action of paracetamol protective agents in mice in vivo. Biochem Pharmacol 1984;33:2995-3000.
11. Halliwell B, Gutterridge JMC. Free radicals in biology and medicine. Oxford: Oxford University Press, 1999;840-842.
12. Cotgreave IA. N-acetyleysteine pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997;38:205-227.
13. Kharazmi A, Nielsen H, Schiotz PO. N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol 1988; 10: 39-46.
14. Schmidt H, Schmidt W, Muller T, Bohrer H, Gebhard MM, Martin E. N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Crit Care Med 1997;25:858-863.
15. Spapen H, Zhang H, Demanent C, Vleminckx W, Vincent JL, Huyghens L. Does N-acetylcysteine influence cytokine response during early human septic shock? Chest 1998; 113:1616-1624.
16. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2:1097-1100.
17. Smilkestein MJ, Knapp JL, Kulig KW, Rumak BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 1988;319:1557-1562.
18. Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990;335:1572-1573.
19. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial, BMJ 1991;303:1026-1029.
20. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852-1857.
21. Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: paediatric aspects. Semin Liver Dis 1996; 16:349-355.
22. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infections in acute liver failure: an analysis of fifty patients. Hepatology 1990;11:49-53.
23. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32(Pt 1):734-739.
24. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991;12:1-9.
25. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996;16:389-402.
26. Macdougall BR, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet 1977;1:617-619.
27. Devictor D, Desplanques L, Debray D, Ozier Y, Dubousset AM, Valayer J, et al. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 1992;16:1156-1162.
28. de Rave S, Tilanus HW, van der Linden J, de Man RA, van der Berg B, Hop WC, et al. The importance of orthotopic liver transplantation in acute hepatic failure. Transpl Int 2002;15:29-33.
29. Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 2003;237:666-675.
30. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991;20:1058-1063.
31. Bateman DN, Woodhouse KW, Rawlins MD. Adverse reactions to N-acetylcysteine. Human Toxicol 1984;3:393-398.
32. Mant TG, Tempowski JH, Volans GN, Talbot JC. Adverse reactions to acetylcysteine and effects of overdose. BMJ 1984;289:217-219.
33. Tenenbein M. Hypersensitivity-like reactions to N-acetylcysteine. Vet Hum Toxicol 1984;26:3-5.
34. Dawson AH, Henry DA, McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust 1989;150:329-331.
35. Falk JL Oral N-acetylcysteine given intravenously for acetaminophen overdose: we shouldn't have to but we must. Crit Care Med 1998;26:7.